Historique
Rapport
WHO expert committee on drug dependence. Critical review report: N-Ethylnorpentylone
Accompagne :
Auteur(s) :
OMS / WHO ;
Expert Committee on Drug Dependence, Forty-first Meeting (12-16 November 2018; Geneva, Switzerland)
Article en page(s) :
30 p.
Sous-type de document :
Revue de la littérature / Literature review
Refs biblio. :
62
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
CANNABIS
;
PHARMACOLOGIE
;
CHIMIE
;
FABRICATION
;
CATHINONES
;
EFFET SECONDAIRE
;
TOXICOLOGIE
Note générale :
This is an advance copy distributed to the participants of the 41st Expert Committee on Drug Dependence.
Résumé :
N-Ethylnorpentylone (IUPAC name: 1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) is a ring-substituted synthetic cathinone analog. It originally emerged in the 1960s during pharmaceutical drug development efforts. Another common name used widely is N-ethylpentylone. On the streets, N-ethylnorpentylone is most likely available as the racemic mixture and it might be obtained from Internet retailers. In the United States of America (USA), this substance was detected for the first time in 2014 but began to emerge more prominently in 2016 both in the USA and other UN Member States. Seizures indicate that N-ethylnorpentylone is available in powder, crystal, rock, capsule, and tablet forms. Examples exist where this drug has been surreptitiously sold as 'ecstasy'/MDMA.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |